Literature DB >> 23757131

The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups.

Olivier Clermont1, Julia K Christenson, Erick Denamur, David M Gordon.   

Abstract

There is extensive genetic substructure within the species Escherichia coli. In 2000 a simple triplex PCR method was described by Clermont and colleagues that enables an E. coli isolate to be assigned to one of the phylo-groups A, B1, B2 or D. The growing body of multi-locus sequence data and genome data for E. coli has refined our understanding of E. coli's phylo-group structure and eight phylo-groups are now recognized: seven (A, B1, B2, C, D, E, F) belong to E. coli sensu stricto, whereas the eighth is the Escherichia cryptic clade I. Here a new PCR-based method is developed that enables an E. coli isolate to be assigned to one of the eight phylo-groups and which allows isolates that are members of the other cryptic clades (II to V) of Escherichia to be identified. The development of the method is described and the method is validated. Over 95% of E. coli isolates can be correctly assigned to a phylo-group. Two collections of human faecal isolates were screened using the new phylo-group assignment method demonstrating that about 13% of E. coli isolates belong to the newly described phylo-groups C, E, F and clade I.
© 2012 Society for Applied Microbiology and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23757131     DOI: 10.1111/1758-2229.12019

Source DB:  PubMed          Journal:  Environ Microbiol Rep        ISSN: 1758-2229            Impact factor:   3.541


  458 in total

1.  The Role of Gram-Negative Bacteria in Urinary Tract Infections: Current Concepts and Therapeutic Options.

Authors:  Payam Behzadi; Edit Urbán; Mária Matuz; Ria Benkő; Márió Gajdács
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  VIM-1, VIM-34, and IMP-8 Carbapenemase-Producing Escherichia coli Strains Recovered from a Portuguese River.

Authors:  Nicolas Kieffer; Laurent Poirel; Lucinda J Bessa; Ana Barbosa-Vasconcelos; Paulo Martins da Costa; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Comparative prevalence of Escherichia coli carrying virulence genes and class 1 and 2 integrons in sub-tropical and cool temperate freshwater.

Authors:  Jatinder P S Sidhu; Paul Jagals; Amy Smith; Simon Toze
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-21       Impact factor: 4.223

4.  The Arginine Deiminase Operon Is Responsible for a Fitness Trade-Off in Extended-Spectrum-β-Lactamase-Producing Strains of Escherichia coli.

Authors:  Typhaine Billard-Pomares; Olivier Clermont; Miguel Castellanos; Fatma Magdoud; Guilhem Royer; Bénédicte Condamine; Stéphanie Fouteau; Valérie Barbe; David Roche; Stéphane Cruveiller; Claudine Médigue; Dominique Pognard; Jeremy Glodt; Sara Dion; Odile Rigal; Bertrand Picard; Erick Denamur; Catherine Branger
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

5.  Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.

Authors:  Brian D Johnston; Paul Thuras; Stephen B Porter; Melissa Anacker; Brittany VonBank; Paula Snippes Vagnone; Medora Witwer; Mariana Castanheira; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

6.  The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012).

Authors:  James R Johnson; Stephen Porter; Paul Thuras; Mariana Castanheira
Journal:  Open Forum Infect Dis       Date:  2017-05-02       Impact factor: 3.835

7.  Cross-Border Emergence of Escherichia coli Producing the Carbapenemase NDM-5 in Switzerland and Germany.

Authors:  Trinad Chakraborty; Mustafa Sadek; Yancheng Yao; Can Imirzalioglu; Roger Stephan; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

8.  Colonization with Escherichia coli Strains among Female Sex Partners of Men with Febrile Urinary Tract Infection.

Authors:  Peter Ulleryd; Torsten Sandberg; Flemming Scheutz; Connie Clabots; Brian D Johnston; Paul Thuras; James R Johnson
Journal:  J Clin Microbiol       Date:  2015-04-01       Impact factor: 5.948

9.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

10.  Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli Contamination of 56 Public Restrooms in the Greater Minneapolis-St. Paul Metropolitan Area.

Authors:  Muhanad Mohamed; Kris Owens; Abby Gajewski; Connie Clabots; Brian Johnston; Paul Thuras; Michael A Kuskowski; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.